Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genetimes Technology Named as Nanoink’s New Distributor in China

Published: Thursday, January 24, 2013
Last Updated: Thursday, January 24, 2013
Bookmark and Share
Will distribute NanoInk's NLP 2000 System and DPN 5000 System.

NanoInk’s NanoFabrication Systems Division has announced that it has reached a non-exclusive agreement with Genetimes Technology Inc. to serve as its distributor in China.

Genetimes will distribute NanoInk's desktop nanofabrication equipment, including the NLP 2000 System and the DPN 5000 System, which have a wide range of applications ranging from nanoarray-based protein analysis to cell biology research.

Genetimes is a renowned life science equipment and consumable distributor and is dedicated to developing the nanobiotechnology market in China.

“With branch offices located in 12 cities, Genetimes has already established a strong relationship with NanoInk's target customers in the life science market. Its sales and technical teams have the in-depth knowledge required to understand life science applications, and they have proven expertise in selling technically-sophisticated equipment into that space. With these strengths, Genetimes is the ideal partner for driving sales of NanoInk's unique nanofabrication platforms for use in life science and bioengineering applications,” said Oliver Yeh, General Manager, NanoInk's NanoFabrication Systems Division, Asia-Pacific region.

Yeh continued, “We look forward to a close and successful long-term partnership with Genetimes as we expand our reach in China by promoting the unique capabilities and benefits of innovated NanoFabrication Systems from NanoInk.”

“We are delighted to be appointed as a distributor for NanoInk's products in China’s life science markets,” said Mr. Yuan Zhao, Senior Vice President, Marketing and International Operations at Genetimes Technology.

Mr. Zhao continued, “NanoInk's product lines are complementary to our current product portfolio and are attractive to cell biology markets. We look forward to working with the NanoInk team.”

NanoInk's NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory in an easy to use and affordable platform.

NanoInk's NLP 2000 System is a desktop nanolithography instrument that allows researchers to rapidly design and create custom engineered and functionalized surfaces by using Dip Pen Nanolithography® (DPN®) to transfer minute amounts of materials over a large, environmentally controlled work area.

With the ability to create custom patterns of nano- to microscale features in under an hour, the NLP 2000 System is valuable for protein and biomolecular patterning, microstructure and biosensor functionalization, cell biology and polymer printing applications.

The DPN 5000 System is a full-featured, dedicated instrument for versatile nanopatterning of a variety of materials with nanoscale accuracy and precision. With its user-friendly interface, it is possible to easily design complex patterns while also precisely controlling tip movements during the writing process.

The DPN 5000 System is the ideal platform for nanofabrication, nanomaterials and biomaterials applications that exhibit nanoscale printing, imaging and registration requirements.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NanoInk Recognized as Top Emerging Nanotech Innovators of 2012
Acknowledged for its outstanding contributions in diagnostic testing.
Friday, September 28, 2012
NanoInk Expands Presence in Japan with Prestigious New Distributor
RIBM to market NanoInk’s NLP 2000 system and DPN 5000 system.
Thursday, May 17, 2012
NanoInk Announces Launch of Contract Services Program for Live Single Cell Assay Work
Service offering expected to advance research programs involved with toxicity assessment, high content screening, and cell-cell communication.
Wednesday, February 08, 2012
Leading Romanian Research Institution Expands Capabilities With Purchase of a NanoInk DPN 5000 System
The DPN 5000 System will be used for supramolecular structure fabrication, molecular recognition and self-assembling process applications.
Wednesday, January 18, 2012
NanoInk Retains Lazard as Strategic Advisor
Company to evaluate the strategic alternatives with the assistance of Lazard.
Tuesday, October 18, 2011
Institute of Photonics Purchases NanoInk's NLP 2000 Desktop Nanofabrication System
Plans to use the NLP 2000 for the deposition of soft materials to existing structures to generate optical effects, color conversion and for laser fabrication.
Wednesday, January 19, 2011
NanoProfessor™ Nanoscience Education Program Underway at Dakota County Technical College
Community college students begin hands-on learning with nanotechnology equipment and curriculum.
Wednesday, February 24, 2010
NanoInk Announces the Controlled Deposition of Hydrogels for Applied Bioscience and Biotechnology Research
NanoInk’s patented process of DPN® enables one to directly deposit nanoscale features of the polymer.
Monday, October 12, 2009
The Forschungszentrum Karlsruhe Expands DPN Facility by Adding NanoInk NLP 2000 Nanofabrication Platform
The facility is utilizing the DPN to drive practical applications in the fields of drug discovery, tissue engineering and the early detection of specific diseases.
Wednesday, September 09, 2009
NanoInk® Awarded NIH Grant
Grant will aid development of biologically functional nanostructures and life science screening technologies.
Thursday, August 24, 2006
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!